MA beneficiaries received kidney transplants at nearly half the rate of traditional Medicare patients post-Cures Act, a ...

Novartis's pelacarsen hit its Lp(a) target in 8,323 patients but missed the cardiovascular endpoint entirely, exposing a $6B ...

Arcus Biosciences has $694M in cash to advance its pipeline through pivotal trials, including the Phase 3 PRISM-1 study of ...

YPrime names Greg Wellbrock Chief Data and AI Officer to lead unified data and AI strategy across its clinical trial ...

Fifth Circuit vacates class certification in Filana Therapeutics securities case, removing litigation overhang as company ...

FDA clears Fresenius multiFiltratePRO for regional citrate anticoagulation in acute kidney injury, with integrated pumps and ...

NFL funds $500K study into elevated ALS risk in athletes, veterans, and first responders to identify genetic and biological ...

FDA AI Guidance requires clinical trial sponsors to validate algorithms before submission, shifting documentation and testing ...

OD-001 Phase 2a ulcerative colitis study hits primary endpoint with 2.4-point modified Mayo score reduction at Week 12, ...

Hengrui Pharma presents Phase 3 ruzaltatug data at ESMO 2026, showing progression-free survival endpoint met in EGFR-mutated ...

Veeva launches flat-rate AI pricing and Falcon agentic tools for clinical trials. Explore simplified pricing and platform ...

FDA clears combined use of Restrata Matrix with Solventum V.A.C. Therapy for integrated wound care, enabling simultaneous ...